[Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
R O
RO
Sabadyshin
O Ia
OIa
Slipak
S F
SF
Koval'chuk
V M
VM
D'iakov
V B
VB
Kazimirovskaia
D000085:Acetates / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D014665:Vasodilator Agents / Q000627:therapeutic use
D000085:Acetates; D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D004983:Ethanolamines; D014665:Vasodilator Agents; C047413:crezacin; D007548:Isosorbide Dinitrate
Vliianie trekrezana na perekisnoe okisleniie lipidov u bol'nykh khronicheskoĭ serdechnoĭ nedostatochnosti'iu.